[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352610-105":59,"doc-detail-352610-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","pbrm1-loss-induces-a-permissive-chromatin-state-for-cholangiocytic-differentiation-and-cholangiocarcinoma-formation","Pbrm1 Loss Induces a Permissive Chromatin State for Cholangiocytic Differentiation and Cholangiocarcinoma Formation","","Liver-specific deletion of Pbrm1 reduces chromatin accessibility of hepatocyte gene programs while promoting cholangiocytic differentiation during cholestatic injury. The loss also cooperates with activating mutant KrasG12D to accelerate intrahepatic cholangiocarcinoma development, revealing a lineage-fate control mechanism driven by chromatin remodeling. In Pbrm1 knockout models, cholestatic injury decreases hepatocyte-specific transcription and increases ductular reactions, with additional vulnerability to high-fat diet steatosis. PBRM1-deficient organoids show strong sensitivity to the EZH2 inhibitor tazemetostat.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/pbrm1-loss-induces-a-permissive-chromatin-state-for-cholangiocytic-differentiation-and-cholangiocarcinoma-formation/352610/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/pbrm1-loss-induces-a-permissive-chromatin-state-for-cholangiocytic-differentiation-and-cholangiocarcinoma-formation/352610.png","ImageObject",300,407,{"name":92,"@type":93},"Rhys","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main biological role of PBRM1 described in this study?","Question",{"text":113,"@type":114},"PBRM1 maintains chromatin accessibility for genes involved in hepatocyte differentiation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does Pbrm1 loss affect liver responses during injury and tumorigenesis?",{"text":118,"@type":114},"Pbrm1 loss reduces hepatocyte gene expression after cholestatic injury, enhances ductular reactions, and promotes differentiation toward cholangiocytes during injury or cancer development.",{"name":120,"@type":111,"acceptedAnswer":121},"What is the interaction between Pbrm1 loss and mutant KrasG12D in cancer outcomes?",{"text":122,"@type":114},"Combined Pbrm1 KO/KrasG12D mice have shorter survival and develop cholangiocarcinomas more often, whereas KrasG12D with wild-type Pbrm1 predominantly leads to hepatocellular neoplasms.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352610,1790310677,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207024643,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","ORIGINAL RESEARCH  \nPbrm1 Loss Induces a Permissive Chromatin State for Cholangiocytic Differentiation and Cholangiocarcinoma Formation  \nLi-Wen Chiou, 1 ,2 ,* Yu-Lin Jhuang, 1 ,2 ,* Chia-Lang Hsu,3 Ray-Hwang Yuan,4 ,5 Yen-Hsu Cheng,1 ,2 Chia-Hsiang Lee,2 Yi-Ting Fang,2 Ching-Yao Yang,4 and Yung-Ming Jeng 1 ,2  \n1Graduate Institute of Pathology, National Taiwan University, Taipei, Taiwan; 2Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan; 3Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan; 4Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan; and 5Department of Surgery, National Taiwan University Hospital, Hsinchu Branch, Hsinchu, Taiwan  \nSUMMARY  \nLiver-specific Pbrm1 deletion reduces chromatin accessibility of hepatocytic genes, enhances cholangiocytic differentiation upon injury, and cooperates with mutant Kras to drive intrahepatic cholangiocarcinoma formation, revealing an epigenetic mechanism linking chromatin remodeling to lineage fate and potential EZH2-targeted therapy.  \nBACKGROUND & AIMS: The SWI/SNF ATP-dependent chromatin remodeling complex regulates transcriptional machinery access and is critical in normal physiology and cancer development. PBRM1, a key subunit of this complex, is frequently mutated in intrahepatic cholangiocarcinoma (iCCA) . This study aims to explore the role of PBRM1 in liver physiology and its involvement in iCCA development.  \nMETHODS: Liver-specific Pbrm1 knockout (Pbrm1 KO) mice were generated to assess the effects of Pbrm1 loss under various conditions. These mice were exposed to a 3,5-diethoxycarbonyl-1,4-dihydrocollidine diet to induce cholestatic injury and were also subjected to a high-fat diet to  \nWHAT YOU NEED TO KNOW  \nBackground: PBRM1, a core subunit of the SWI/SNF chromatin-remodeling complex, is frequently mutated in intrahepatic cholangiocarcinoma. However, how PBRM1 loss alters hepatocyte differentiation and promotes cholangiocarcinogenesis remains poorly defined.  \nImpact: Liver-specific Pbrm1 deletion decreases chromatin accessibility of hepatocytic genes, enhances cholangiocytic differentiation during injury, and cooperates with mutant Kras to drive intrahepatic cholangiocarcinoma formation.  \nFuture Directions: Further studies should investigate how other chromatin remodelers compensate for Pbrm1 loss and whether these compensatory mechanisms can be exploited as therapeutic targets.  \nevaluate susceptibility to liver steatosis. Chromatin accessibility and gene expression under both normal and injury conditions were examined. Additionally, the impact of Pbrm1 loss was analyzed in combination with an activating KrasG12D mutation to study cancer development.  \n2 Chiou et al Cellular and Molecular Gastroenterology and Hepatology Vol. 20, Iss. 6  \nRESULTS: Pbrm1 KO mice exhibited increased susceptibility tocholestatic injury, with an enhanced ductular reaction. Loss of Pbrm1 reduced chromatin accessibility at hepatocyte-specific and metabolically important genes, although RNA expression remained unaffected during homeostasis. Following cholestatic injury, hepatocyte-specific gene expression was significantly reduced compared with wild-type controls. Pbrm1 KO mice also showed heightened vulnerability to high-fat diet-induced liver steatosis. When combined with KrasG12D mutation, Pbrm1 KO/KrasG12D mice had shorter survival and were more likely to develop cholangiocarcinomas, whereas Pbrm1 wild type/ KrasG12D mice predominantly developed hepatocellular neoplasms. PBRM1-deficient organoids were highly sensitive to the EZH2 inhibitor tazemetostat, whereas effects on allografts were limited.  \nCONCLUSIONS: PBRM1 maintains chromatin accessibility for hepatocyte differentiation-related genes. Its loss promotes differentiation toward cholangiocytes during injury or tumorigenesis, driving iCCA development. (Cell Mol Gastroenterol Hepatol 2026;20:101720; [https://doi.org/10.1016/](https://doi.org/10.1","cbCaijA0i6WZWmCI","https://ap.wps.com/l/cbCaijA0i6WZWmCI","pdf",30900483,"English","# Summary\n## Background & Aims\n## Methods\n## Results\n## Conclusions","[{\"question\":\"What is the main biological role of PBRM1 described in this study?\",\"answer\":\"PBRM1 maintains chromatin accessibility for genes involved in hepatocyte differentiation.\"},{\"question\":\"How does Pbrm1 loss affect liver responses during injury and tumorigenesis?\",\"answer\":\"Pbrm1 loss reduces hepatocyte gene expression after cholestatic injury, enhances ductular reactions, and promotes differentiation toward cholangiocytes during injury or cancer development.\"},{\"question\":\"What is the interaction between Pbrm1 loss and mutant KrasG12D in cancer outcomes?\",\"answer\":\"Combined Pbrm1 KO/KrasG12D mice have shorter survival and develop cholangiocarcinomas more often, whereas KrasG12D with wild-type Pbrm1 predominantly leads to hepatocellular neoplasms.\"}]","Pbrm1 Loss Induces a Permissive Chromatin State for Cholangiocytic Differentiation and Cholangiocarcinoma Formation | PDF",1790100447,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6530ca6d90e9f30704d08127c240147c.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/992fa68dcc9e0a98a3607d2d8f9a0e42.webp",982,1294,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e50ee45c5397af522771a0d27bcc2720.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4366d47599fd68ce96966fa22cad7716.webp",980,1292]